Ahold names COO of Ahold USA
Amsterdam, the Netherlands — Royal Ahold announced Thursday it has named James McCann as COO of Ahold USA, effective Jan. 1.
McCann, who is the company’s current chief commercial and development officer, replaces Carl Schlicker, who is retiring.
Wal-Mart foreign bribery investigation expands
New York — Wal-Mart Stores reported in a regulatory filing that its investigation into violations of the Foreign Corrupt Practices Act, a federal antibribery law, has extended beyond Mexico to China, India and Brazil.
“Inquiries or investigations regarding allegations of potential FCPA violations have been commenced in a number of foreign markets where we operate, including but not limited to Brazil, China, and India,’’ the company said in a Securities and Exchange Commission filing that accompanied its third-quarter financial results.
In the filing, Wal-Mart said it had “identified or been made aware of’” other potential violations.
“When such allegations are reported or identified, the Audit Committee and the company, together with their third-party advisers, conduct inquiries and when warranted based on those inquiries, open investigations,” the retailer said.
Kroger Co. to buy specialty pharmacy company
Cincinnati — The Kroger Co. said Thursday it will buy specialty pharmacy company Axium Pharmacy Holdings for undisclosed terms.
Axium is one of the nation’s largest independent providers of specialty pharmacy services, offering a range of clinical services to patients with complex chronic conditions. Through its additional pharmacy locations in Puerto Rico, Tennessee and Mississippi, Axium provides comprehensive specialty pharmacy services to patients.
"Kroger and Axium are a strategic fit as we look to enter the high-growth specialty pharmacy business," said Lincoln Lutz, Kroger’s VP corporate pharmacy. "The combination of Axium’s expertise and Kroger’s 1,950 pharmacy locations, 91 Little Clinic locations, and pharmacists who provide health coaching, biometric screening and other wellness services will deliver positive health outcomes for our patients, cost savings for insurance payers, and unique services for physicians."